Psychiatry Flashcards
1
Q
Anxiety NT
A
- increased: NE - decreased: GABA, serotonin
2
Q
Depression NT
A
- decreased: NE, serotonin, dopamine
3
Q
Alzheimer’s NT
A
- decreased; ACh
4
Q
Huntington’s NT
A
- increased: dopamine - decreased: GABA, ACh
5
Q
Schizophrenia NT
A
- increased: dopamine
6
Q
Parkinson’s NT
A
- increased: serotonin, ACh - decreased: dopamine
7
Q
Methylphenidate
- Class - MOA - Use
A
- CNS stimulant
- MOA: increased catecholamines esp NE + dopamine
- Use: ADHD, narcolepsy, appetite control, depression in terminally ill with short time to live
- toxicity: leukopenia, anemia, increased LFT - monitor laps
8
Q
Dextroamphetamine
- Class - MOA - Use
A
- CNS stimulant
- MOA: increased catecholamines esp NE + dopamine
- Use: ADHD, narcolepsy, appetite control
9
Q
Methamphetamine
- Class - MOA - Use
A
- CNS stimulant
- MOA: increased catecholamines esp NE + dopamine
- Use: ADHD, narcolepsy, appetite control
10
Q
Haloperidol
- Class - MOA - Potency - Use - Toxicity
A
- Antipsychotic
- MOA: block dopamine D2 receptor (increase cAMP)
- decanoate available
- High potency (Try to Fly High)
- Use:
- Schizophrenia - positive symptoms
- psychosis
- acute mania
- Tourette’s syndrome
- Toxicity
- Extrapyramidal symptoms- dyskinesia (parkinson like)
- Endocrine- hyperprolactinemia
- Antimuscarinic- dry mouth, constipation
- A1 R blocker- hypotension
- Histamine R blocker- sedation
-
Neuroleptic Malignant Syndrome
- Fever, Encephalopathy, Vitals, Elevated enzymes (CK), Rigidity of muscles
- rigidity, myoglobinuria, autonomic instability, hyperpyrexia
- Treatment: dantrolene, bromocriptine
- Fever, Encephalopathy, Vitals, Elevated enzymes (CK), Rigidity of muscles
-
Tardive Dyskinesia
- stereotypic oral favial movements
- due to long term antipsychotic use
- irreversible
11
Q
EPS side effects
A
- 4 hr = dystonia (muscle spasm, studd, oculogyric crisis)
- benztropine or diphenhydramine
- 4 day = akathisia (restless)
- beta blocker
- 4 week = bradykinesia (parkinosnism)
- benztropine or diphenhydramine
- amantidine or bromocriptine NOT Ldopa
- 4 month = tardive dyskinesia
- no treatment
12
Q
Trifluoperazine
- Class - MOA - Potency - Use - Toxicity
A
- Antipsychotic
- MOA: block dopamine D2 receptor (increase cAMP)
- High potency (Try to Fly High)
- Use:
- Schizophrenia - positive symptoms
- psychosis
- acute mania
- Tourette’s syndrome
- reduce anxiety
- Toxicity
- Extrapyramidal symptoms- dyskinesia (parkinson like)
- Endocrine- hyperprolactinemia
- Antimuscarinic- dry mouth, constipation
- A1 R blocker- hypotension
- Histamine R blocker- sedation
13
Q
Fluphenazine
- Class - MOA - Potency - Use - Toxicity
A
- Antipsychotic
- MOA: block dopamine D2 receptor (increase cAMP)
- **decanoate available **
- High potency (Try to Fly High)
- Use:
- Schizophrenia - positive symptoms
- psychosis
- acute mania
- Tourette’s syndrome
- Toxicity
- Extrapyramidal symptoms- dyskinesia (parkinson like)
- Endocrine- hyperprolactinemia
- Antimuscarinic- dry mouth, constipation
- A1 R blocker- hypotension
- Histamine R blocker- sedation
14
Q
Thioridazine
- Class - MOA - Potency - Use - Toxicity
A
- Antipsychotic
- MOA: block dopamine D2 receptor (increase cAMP)
- Low potency (Cheating Thieves are Low)
- Use:
- Schizophrenia - positive symptoms
- psychosis
- acute mania
- Tourette’s syndrome
- Toxicity
- Extrapyramidal symptoms- dyskinesia (parkinson like)
- Endocrine- hyperprolactinemia
- Antimuscarinic- dry mouth, constipation
- A1 R blocker- hypotension
- Histamine R blocker- sedation
- **Retinal deposits **
- Prolonged QTc
15
Q
Chlorpromazine
- Class - MOA - Potency - Use - Toxicity
A
- Antipsychotic
- MOA: block dopamine D2 receptor (increase cAMP)
- Low potency (Cheating Thieves are Low)
- Use:
- Schizophrenia - positive symptoms
- psychosis
- acute mania
- Tourette’s syndrome
- **N/V/intractable hiccups **
- Toxicity
- Extrapyramidal symptoms- dyskinesia (parkinson like)
- Endocrine- hyperprolactinemia
- Antimuscarinic- dry mouth, constipation
- A1 R blocker- hypotension
- Histamine R blocker- sedation
- **Corneal deposits **
- **purple grey metallic rash over sun exposed areas and jaundice **
16
Q
Olazapine
- Class - MOA - Use - Toxicity
A
- Atypical antipsychotic
- MOA: not understood
- Use:
- Schizophrenia- positive/negative symptoms
- Bipolar disorder
- OCD - if moderate response to SSRI
- Depression
- Anxiety disorder
- Mania
- Tourette’s
- Toxicity:
- weight gain
- sedation
17
Q
Quetiapine
- Class - MOA - Use - Toxicity
A
- Atypical antipsychotic
- MOA: not understood
- Use:
- Schizophrenia- positive/negative symptoms
- Bipolar disorder
- OCD- if moderate response to SSRI
- Depression
- Anxiety disorder
- best atypical for anxiety
- Mania
- Tourette’s
- Toxicity
- sedation
- orthostatic hypotension
18
Q
Clozapine
- Class- MOA - Use - Toxicity
A
- Atypical antipsychotic
- MOA: not understood
- Use:
- Schizophrenia- positive/negative symptoms
- refractory to other meds
- best antipsychotic but serious side effects
- only antipsychotic to decrease risk of suicide
- Bipolar disorder
- OCD - if moderate response to SSRI
- Depression
- Anxiety disorder
- Mania
- Tourette’s
- Schizophrenia- positive/negative symptoms
- Toxicity:
- weight gain
- agranulocytosis - need weekly WBC monitor
- seizure
- less likely to cause EPS
- doesc not affect prolactin
19
Q
Risperidone
- Class- MOA- Use- Toxicity
A
- Atypical antipsychotic
- MOA: not understood
- Use:
- Schizophrenia- positive/negative symptoms
- Bipolar disorder
- OCD - if moderate response to SSRI
- Depression
- Anxiety disorder
- Mania
- Tourette’s
- Toxicity:
- hyperprolactinemia
- highest risk EPS of atypicals
- orthostatic hypotension + reflex tachy
- long acting injectable
20
Q
Aripripazole
- Class- MOA- Use - Toxicity
A
- Atypical antipsychotic
- MOA: D2 partial agonist
- Use:
- Schizophrenia- positive/negative symptoms
- Bipolar disorder
- OCD - if moderate response to SSRI
- Depression
- Anxiety disorder
- Mania
- Tourette’s
- Toxicity:
- more activating (akathisia) and less sedating
- weight neutral
21
Q
Ziprasidone
- Class- MOA - Use- Toxicity
A
- Atypical antipsychotic
- MOA: not understood
- Use:
- Schizophrenia- positive/negative symptoms
- Bipolar disorder
- OCD - if moderate response to SSRI
- Depression
- Anxiety disorder
- Mania
- Tourette’s
- Toxicity:
- prolong QT interval
- weight neutral
22
Q
Lithium
Class- MOA- Use- Toxicity
A
- Mood stabilizer
- MOA: inospital triphosphate suppressor
- Use:
- Mood stabilizer - bipolar disorder
- only one to decrease suicide
- cyclothymia
- unipolar depression
- blocks relapse and acute manic events
- SIADH
- Mood stabilizer - bipolar disorder
- Toxicity:
- Movement (tremor)
- Nephrogenic Diabetes insipidus (polyuria)
- hypOthyroidism
- Pregnancy - ebstein anomoly and malformation of great vessels
- apical displacement of tricupsid valve
- AMS, convulsions, death
- GI disturbance, weight gain, sedation, leukocytosis
- Excretion
- kidneys
- onset of action 5-7 days
- reabsorbed in proximal tubule following nA+
- renal injury, drugs, drigs that increase proximal tubule na+ absorption can increase lithium levels (Thiazide, NSAID, ACE inhibitor)
23
Q
Valproic Acid
- MOA - Use- Toxcity
A
- MOA: increase Na+ channel inactivation, increase [GABA]
- Use: mood stabilizer- bipolar disorder
- esp use if poor kidney fxn
- Toxicity
- GI distress
- hepatotoxicity- fatal
- Pancreatitis
- tremor
- wt gain
- sedation
- alopecia
- thrombocytopenia
- Spina bifida
24
Q
Carbamazapine
- MOA- Use- Toxicity
A
- MOA: increase na+ channel inactivation
- 5-7 day onset of action
- Use:
- mood stabilizer- bipolar
- esp mixed episodes and rapid cycling
- trigeminal neuralgia
- mood stabilizer- bipolar
- Toxicity:
- most common: GI and CNS (drosiness, ataxia, sedation, confusion)
- leukopenia, hyponatremia, thrombocyopenia
- diplopia
- ataxia
- agranulocytosis, aplastic anemia
- liver toxicity
- teratogenesis - neural tube defect
- CYP P450 inducer
- SIADH
- Steven johnson syndrome
25
Buspirone
- MOA- Use- Toxicity
* MOA: 5HT R stimulator
* Use:
* Generalized anxiety disorder
* 1-2 weeks to have effect
* Toxicity:
* NO sedation, addiction, or tolerance
* does NOT interact with alcohol
26
Fluoxetine
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: SSRI
* longer half life with active metabolite so SSRI discontinuation syndrome less common
* no tapering necessary
* Use:
* depression
* generalized anxiety disorder
* panic disorder
* OCD - SSRI better then antipsychotics
* bulimia
* social phobias
* PTSD
* Toxicity
* GI distress
* **Sexual dysfunction** (decrease libido)
* **Serotonin syndrome**
* with any drug that increase serotonin
* MAO inhibitor, SNRI, TCA
* hyperthermia / confusion / myoclonus / CV collapse / flushing / diarrhea / seizures / Treatment
* treatment: *cyproheptadine*
* Class C - potentially harmful in pregnancy according to animal studies
* need to discuss risk and benefits with patient
* **approved in children **
* **More common sleep changes and anxiety **
* **can increase level of neuroleptics **
* Extra
* - 4-8 weeks to have effect
27
Paroxetine
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: SSRI
* shortest hald life = **withdrawal phenomenon most common **
* Use:
* depression
* generalized anxiety disorder
* panic disorder
* OCD
* bulimia
* social phobias
* PTSD
* Toxicity
* GI distress
* **Sexual dysfunction** (decrease libido)
* **Serotonin syndrome**
* with any drug that increase serotonin
* MAO inhibitor, SNRI, TCA
* hyperthermia / confusion / myoclonus / CV collapse / flushing / diarrhea / seizures / Treatment
* treatment: cyproheptadine
* Teratogenic- persistent pulmonary hypertension of the newborn
* avoid in patients with dementia
* Extra
* 4-8 weeks to have effect
* **most drug drug interactions**
* **more anticholinergic effects **
28
Setraline
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: SSRI
* Use:
* depression
* generalized anxiety disorder
* panic disorder
* OCD
* bulimia
* social phobias
* PTSD
* Toxicity
* **GI distress**
* **sleep changes **
* Sexual dysfunction (decrease libido)
* Serotonin syndrome
* with any drug that increase serotonin
* MAO inhibitor, SNRI, TCA
* hyperthermia / confusion / myoclonus / CV collapse / flushing / diarrhea / seizures / Treatment
* treatment: cyproheptadine
* Teratogenic- persistent pulmonary hypertension of the newborn
* Extra
* 4-8 weeks to have effect
29
Citalopram
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: SSRI
* Use:
* depression
* generalized anxiety disorder
* panic disorder
* OCD
* bulimia
* social phobias
* PTSD
* Toxicity
* GI distress
* **Sexual dysfunction** (decrease libido)-- fewer
* **Serotonin syndrome**
* with any drug that increase serotonin
* MAO inhibitor, SNRI, TCA
* hyperthermia / confusion / myoclonus / CV collapse / flushing / diarrhea / seizures / Treatment
* treatment: cyproheptadine
* Teratogenic- persistent pulmonary hypertension of the newborn
* Extra
* 4-8 weeks to have effect
* fewest drug drug interactions
30
Venlafaxine
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: SNRI (serotonin and NE reuptake inhibitor)
* Use:
* depression
* generalized anxiety
* panic disorders
* Toxicity:
* **increase BP**
* sedation
* nausea
* esp increase risk of mania if given to bipolar
31
Duloxetine
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: SNRI (serotonin + NE reuptake inhibitor)
* greater NE effect
* Use:
* Depression
* Diabetic peripheral neuropathy
* Toxicity:
* increase BP
* sedation, dry mouth, constipation more due to NE effects
* nausea
* liver side effects in patients with liver disease
32
Amitriptyline
- Class- MOA- Use- Toxicity
* Tricyclic antidepressant
* MOA: block NE and serotonin reuptake
* Use:
* major depression
* fibromyalgia, chronic pain, migrains, insomnia
* Toxicity:
* H1 antagonist = sedation
* a1 blocking = postural hypotension
* anticholinergic = tachy, urinary retention, dry mouth
* **Convulsion**
* **Coma**
* **Cardiotoxicity** - arrythmia
* treat = NaHCO3
* respiratory depression
* hyperpyrexia
* confusion and hallucination in eldery
33
Nortriptyline
- Class- MOA- Use- Toxicity
* Tricyclic antidepressant
* MOA: block NE and serotonin reuptake
* Use:
* major depression
* use in elderly
* fibromyalgia
* Toxicity:
* H1 antagonist = sedation
* a1 blocking = postural hypotension
* anticholinergic = tachy, urinary retention, dry mouth
* **Convulsion**
* **Coma**
* **Cardiotoxicity** - arrythmia
* treat = NaHCO3
* respiratory depression
* hyperpyrexia
* **LESS confusion and hallucination in eldery**
* **Least likely to cause orthostatic hypotension**
34
Imipramine
- Class- MOA- Use- Toxicity
* Tricyclic antidepressant
* MOA: block NE and serotonin reuptake
* Use:
* major depression
* fibromyalgia
* **bedwetting **
* **panic disorder **
* **PTSD**
* Toxicity:
* H1 antagonist = sedation
* a1 blocking = postural hypotension
* anticholinergic = tachy, urinary retention, dry mouth
* **Convulsion**
* **Coma**
* **Cardiotoxicity** - arrythmia
* treat = NaHCO3
* respiratory depression
* hyperpyrexia
* confusion and hallucination in eldery
35
Despiramine
- Class- MOA- Use- Toxicity
* Tricyclic antidepressant
* MOA: block NE and serotonin reuptake
* Use:
* major depression
* fibromyalgia
* Toxicity:
* H1 antagonist = sedation
* a1 blocking = postural hypotension
* anticholinergic = tachy, urinary retention, dry mouth
* **Convulsion**
* **Coma**
* **Cardiotoxicity** - arrythmia
* treat = NaHCO3
* respiratory depression
* hyperpyrexia
* confusion and hallucination in eldery
* **\*\* less sedating and higher seizure threshold **
36
Clomipramine
- Class- Use- MOA- Toxicity
* Tricyclic antidepressant
* MOA: block NE and serotonin reuptake
* Use:
* major depression
* fibromyalgia
* **OCD** - bc has greater serotonin effect
* panic
* Toxicity:
* H1 antagonist = sedation
* a1 blocking = postural hypotension
* anticholinergic = tachy, urinary retention, dry mouth
* **Convulsion**
* **Coma**
* **Cardiotoxicity** - arrythmia
* treat = NaHCO3
* respiratory depression
* hyperpyrexia
* confusion and hallucination in eldery
37
Doxepin
- Class- MOA- Use- Toxicity
* Tricyclic antidepressant
* MOA: block NE and serotonin reuptake
* Use:
* major depression
* fibromyalgia, chonic pain
* PTSD
* Toxicity:
* H1 antagonist = sedation
* a1 blocking = postural hypotension
* anticholinergic = tachy, urinary retention, dry mouth
* **Convulsion**
* **Coma**
* **Cardiotoxicity** - arrythmia
* treat = NaHCO3
* respiratory depression
* hyperpyrexia
* confusion and hallucination in eldery
38
Amoxapine
- Class- MOA- Use- Toxicity
* Tricyclic antidepressant
* MOA: block NE and serotonin reuptake
* blocks post synaptic dopamine receptors
* Use:
* major depression
* **monotherapy for major depression with psychotic features **
* fibromyalgia
* Toxicity:
* H1 antagonist = sedation
* a1 blocking = postural hypotension
* anticholinergic = tachy, urinary retention, dry mouth
* **Convulsion**
* **Coma**
* **Cardiotoxicity** - arrythmia
* treat = NaHCO3
* respiratory depression
* hyperpyrexia
* confusion and hallucination in eldery
* may cause EPS due to dopamine block
* **Do NOT use in depressed patient with parkinson **
39
Tranylcypromine
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: MAOI
* Increase levels of NE, Serotonin, Dopamine
* Use:
* atypical depression
* anxiety
* hypochondriasis
* Toxicity:
* toxic in overdose - rhabdomyolysis
* **hypertensive crisis**
* esp with ingestion of tyramine foods
* cheese, wine
* treat = phentolamine = alpha receptor blocker
* CNS stimulation
* Serotonin syndrome
* dont give with- SSRI, TCA, St. John's Wort, Meperidine, Dextromethorphan
40
Phenelzine
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: MAOI
* Increase levels of NE, Serotonin, Dopamine
* Use:
* atypical depression
* anxiety
* hypochondriasis
* Toxicity:
* toxic in overdose
* **hypertensive crisis**
* esp with ingestion of tyramine foods
* cheese, wine
* treat = phentolamine = alpha receptor blocker
* CNS stimulation
* Serotonin syndrome
* dont give with- SSRI, TCA, St. John's Wort, Meperidine, Dextromethorphan
41
Isocarboxazid
- Class- MOA- Use- Toxicity
* Anti-depressant
* MOA: MAOI
* Increase levels of NE, Serotonin, Dopamine
* Use:
* atypical depression
* anxiety
* hypochondriasis
* Toxicity:
* toxic in overdose - rhabdomyolysis
* **hypertensive crisis**
* esp with ingestion of tyramine foods
* cheese, wine
* treat = phentolamine = alpha receptor blocker
* CNS stimulation
* Serotonin syndrome
* dont give with- SSRI, TCA, St. John's Wort, Meperidine, Dextromethorphan
42
Selegiline
- Class- MOA - Use- Toxicity
* Anti-depressant
* MOA: selective MAO-B inhibitor
* Increase levels of NE, Serotonin, Dopamine
* **NO DIET RESTRICTIONS**
* Use:
* atypical depression
* anxiety
* hypochondriasis
* *comes in patch form*
* Toxicity:
* toxic in overdose - rhabdomyolysis
* **hypertensive crisis**
* esp with ingestion of tyramine foods
* cheese, wine
* treat = phentolamine = alpha receptor blocker
* CNS stimulation
* Serotonin syndrome
* dont give with- SSRI, TCA, St. John's Wort, Meperidine, Dextromethorphan
43
Buproprion
* Class- MOA- Use- Toxicity
* Atypical antipsychotic
* MOA: increase NE + dopamine
* Use:
* Depression
* Smoking sessation
* Toxicity:
* tachycardia
* insomnia
* headache
* seizures in bulemic patient
* NO sexual side effects
44
Mirtazapine
- Class- MOA- Use- Toxicity
* Atypical antidepressant
* MOA:
* alpha-2 antagonist
* increase NE and serotonin release
* Use
* depression
* think skinny old woman who can't sleep
* Toxicity
* sedation
* increased appetite
* weight fain
* dry mouth
45
Maprotiline
- Class- MOA- Use- Toxicity
* Atypical antidepressant
* MOA: block NE reuptake
* Use: depression
* Toxicity:
* sedation
* orthostatic hypotension
* seizures, arrythymia
46
Trazadone
- Class- Use- MOA- Toxicity
* Atypical antidepressnat
* MOA: primarily inhibits serotonin reuptake
* Use:
* insomnia
* depression
* Toxicity
* priapism
* sedation
* nausea
* postural hypotension
* no sexual side effects of SSRI
* no effect on REM sleep
47
Methadone
- MOA- Use
* long acting oral opiate
* heroin detoxification or long term maintanence
* when discontinued has slow release from tissues at low levels to extend withdrawal but lessen symptoms
48
Naloxone + Buprenorphine
-MOA- Use- Toxicity
* **Buprenorphine = partial agonist**
* **Naloxone = antagonist**
* **together = suboxone **
* long acting
* Use: heroin addition
* fewer withdrawal symptoms then methadone
* not active hwen oral so no withdrawal symptoms
49
Phenobarbital / Pentobarbital/ secobarbital
- Class- MOA- Use- Toxicity
* Barbituate
* MOA: increase _duration_ of Cl- channel opening decreasing neuron firing
* Use:
* sedation for -
* anxiety
* seizures
* insomnia
* Toxicity:
* respiratory depression
* CV depression
* CNS depression
* dependence
* induce P450
50
Diazepam
- Class- MOA- Use- Toxicity
* Benzodiazepine
* MOA: increase frequebct of Cl- channel opening
* long 1/2 live
* metabolized by liver
* Use:
* anxiety
* spasticity
* status epilecticus
* detoxification
* night terrors
* sleep walking
* insomnia
* Toxicity:
* dependence
* CNS depression with alcohol
* Treat overdose = flumazenil
51
Lorazepam
- Class- MOA- Use- Toxivity
* Benzodiazepine
* MOA: increase frequebct of Cl- channel opening
* long 1/2 live
* metabolization not dependent on liver
* Use:
* panic attacks
* alcohol and sedative hynotic detox
* agitation
* Toxicity:
* dependence
* CNS depression with alcohol
* Treat overdose = flumazenil
52
Triazolam
- Class- MOA- Use- Toxicity
* Benzodiazepine
* MOA: increase frequebct of Cl- channel opening
* *short 1/2 live (TrOM)*
* Use:
* anxiety
* spasticity
* status epilecticus
* detoxification
* night terrors
* sleep walking
* insomnia
* Toxicity:
* dependence
* CNS depression with alcohol
* Treat overdose = flumazenil
53
Oxazepam
- Class- MOA- Use- Toxicity
* Benzodiazepine
* MOA: increase frequebct of Cl- channel opening
* *short 1/2 live (TroM)*
* *metabolization not dependent on liver *
* Use:
* sedative
* alcohol or sedative detox
* Toxicity:
* dependence
* CNS depression with alcohol
* Treat overdose = flumazenil
54
Midazolam
- Class- MOA- Use- Toxicity
* Benzodiazepine
* MOA: increase frequebct of Cl- channel opening
* *short 1/2 live (TrOM)*
* Use:
* anxiety
* spasticity
* status epilecticus
* detoxification
* night terrors
* sleep walking
* insomnia
* Toxicity:
* dependence
* CNS depression with alcohol
* Treat overdose = flumazenil
55
Temazepam
- Class- MOA- Use - Toxicity
* Benzodiazepine
* MOA: increase frequebct of Cl- channel opening
* long 1/2 live
* not metabolized by liver
* Use:
* insomnia
* primarily used in medical and surgical setting
* Toxicity:
* dependence
* CNS depression with alcohol
* Treat overdose = flumazenil
56
Chlordiazepoxide
- Class- MOA- Use- Toxicity
* Benzodiazepine
* MOA: increase frequebct of Cl- channel opening
* long 1/2 live
* metabolized by liver
* Use:
* anxiety
* spasticity
* status epilecticus
* detoxification
* night terrors
* sleep walking
* insomnia
* Toxicity:
* dependence
* CNS depression with alcohol
* Treat overdose = flumazenil
57
Aprazolam
- Class- MOA- Use- Toxicity
* Benzodiazepine
* MOA: increase frequebct of Cl- channel opening
* long 1/2 live
* Use:
* anxiety
* panic attacks
* Toxicity:
* dependence
* high abuse potential
* CNS depression with alcohol
* Treat overdose = flumazenil
58
Clonazepam
- MOA- Use- Toxicity
* Benzodiazpine
* MOA: increase frequebct of Cl- channel opening
* Most potent
* Use:
* anxiety
* panic disorder
* Toxicity:
* dependence
* CNS depression with alcohol
* Treat overdose = flumazenil
* avoid with renal dysfunction
59
Modafenil
* narcolepsy treatment
* novel stimulant
* preferred over amphetamines because amphatamines cause risk of dependance, abuse, tolerance
60
OCD treatment
* SSRI- fluoxetine, fluvoxamine, paroxetine, setraline
* Clomipramine = TCA
61
Tourette
* Atipcal neuroleptics -- Respiridone
* Alpha 2 agonist -- clonidine
* Severe cases
* typical neuroleptics -- haloperidol, primozide
62
PTSD
* SSRI = setraline or paroxetine
* alpha blocker = prazosin
* TCA = imipramine, doxepin
* MAOI
63
Bulemia Nervosa
* Fluoxetine
64
panic disorder
* SSRI = setraline and paroxetine
* Imipramine
* Clomipramine
* benzo = immediate
* venlafazine
65
GAD
* antidepressant - SSRI, buspirone, venlafaxine
* benzo- clozepam, diazepam
66
esciptalopram
* Anti-depressant
* MOA: SSRI
* Use:
* depression
* generalized anxiety disorder
* panic disorder
* OCD - SSRI better then antipsychotics
* bulimia
* social phobias
* PTSD
* Toxicity
* GI distress
* Sexual dysfunction (decrease libido)
* Serotonin syndrome
* with any drug that increase serotonin
* MAO inhibitor, SNRI, TCA
* hyperthermia / confusion / myoclonus / CV collapse / flushing / diarrhea / seizures / Treatment
* treatment: cyproheptadine
* Teratogenic- persistent pulmonary hypertension of the newborn
* Extra
* - 4-8 weeks to have effect
* expensive
* fewer side effects
67
Anorexia nervosa
* cognitive behavioral therapy
* nutritional rehab
* Olanzapine if not response to others
68
Delusional disorder
* Antipsychotics
69
ADHD
* Stimulants- mehlphenidate, dextroamphetamine, amphetamine salts
* atamoxatine - nonstimulant
* alpha 2 agonist- clonidine, gunfacine
70
Nefazodone
MOA- Use- Toxicity
* SSRI
* Benefit: no sexual dysfunction
* toxicity: hepatits and liver failure (black box warning)
* RARELY USED
71
Lamotrigine
* Antieleptic
* Use: depressive episodes of bipolar
* Toxicity:
* Rash
* Steven Jphnson syndrome
* ataxia
* nausea
* sedation
72
fluvoxamine
* SSRI
* OCD
* side effects: n, v, drug interactions
73
typical antipsychotic
* block dopamine D2 receptors
* low potency = higher incidence anticholinergic adn antihistamien effects
* high potency = higher incidence of EPS and NMS
* more lethality in overdose due to QT prolongation
74
atypical antipsychotic
* blocks dopamien 2A and serotonin 2A receptors
* increase risk of all cause mortality and stroke in elderly
* decreased risk EPS, tardive dyskinesia, NMS
75
dopamine pathways
* Mesolimbic = (+) symptoms
* nucleus accumbens, fornix, amygdala, hippocampus
* Mesocortical = (-) symptoma
* Nigrostriatal = EPS
* Tubuloinfundibular = prolactin
76
diazepam
* Benzo
* rapid onset
* use
* detoxification from alcohol or sedative hyponotics anxyiolytic
* seizures
77
hydroxyzine
* antihistamine
* side effects: sedation, dry mouth, constipation, urinary retention, blurred vision
* use: quick acting anxiolytic but cant take benzo
78
donepezil
galantamine
rivastigmine
tacrine
memantine
acetylcholinesterase inhibitors
79
overdose treatment
* Benzo = flumazenil
* Barbituate = NaHCO3
* Opiate = Naloxone